发明名称 |
Multicomponent crystalline system comprising nilotinib and selected co-crystal formers |
摘要 |
<p>The present invention relates to crystalline materials comprising nilotinib and a carboxylic acid, carboxylic acid ester, carboxylic acid amide or sulfonic acid as a co-crystal former, and to pharmaceutical compositions comprising said materials. The invention also relates to processes for preparing said crystalline materials and to methods of using said crystalline materials to treat a disease condition in which tyrosine kinase inhibition is beneficial.</p> |
申请公布号 |
AU2013333953(A1) |
申请公布日期 |
2015.04.30 |
申请号 |
AU20130333953 |
申请日期 |
2013.10.16 |
申请人 |
BASF SE |
发明人 |
CHIODO, TIZIANA;HAFNER, ANDREAS;HINTERMANN, TOBIAS;SALVADOR, BEATE;SZELAGIEWICZ, MARTIN;BLATTER, FRITZ;RODEL, EVA;VOSSEN, MARCUS |
分类号 |
C07D401/14;A61K31/506;A61P35/02 |
主分类号 |
C07D401/14 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|